October 1, 2021
Friday | 12:00 - 16:00 (GMT+3)
Session I: | |
---|---|
12:00 – 12:25 | 40 Years of Experience in Pediatric Hematology and Oncology in Lithuania Jelena Rascon, MD, PhD, Vilnius University Hospital Santaros Klinikos, Lithuania |
12:25 – 12:50 | Achievements in reducing early toxicity for pediatric ALL patients in Lithuania during time periods Goda Elizabeta Vaitkevičienė, MD, PhD, Vilnius University Hospital Santaros Klinikos, Lithuania |
12:50 – 13:10 | ALL treatment results in Latvia Anna Valaine, MD, PhD, Children's Clinical University Hospital, Latvia |
13:10– 13:30 | Optimization of Treatment Outcomes in Estonian Pediatric AML Population Kadri Saks, Tallinn Children´s Hospital, Estonia |
13:30 – 13:45 | Discussion |
13:45 – 14:00 | Break |
Session II Moderators: Jelena Rascon ir Rosita Kiudelienė | |
---|---|
14:00– 14:45 | Late complications in childhood cancer survivors and transition from pediatric to adult healthcare Marianne Jarfelt, MD, PhD, Sahlgrenska University Hospital, Göteborg, Sweden |
14:45 – 15:05 | Follow-up after childhood cancer treatment Rūta Maškė, MD, Lithuanian University of Health Sciences |
15:05– 15:25 | Persistent IDA - what other underlying disease can it mask? Monika Kapitančukė, MD, Vilnius University Hospital Santaros Klinikos, Lithuania |
15:25– 15:45 | Relationship between proteinuria and venous thromboembolism? Sonata Šaulytė Trakymienė, MD, PhD, Vilnius University Hospital Santaros Klinikos, Lithuania |
15:45 – 16:00 | Discussion |